#health-policy
Canada Assisted Dying Rules Tightened Amid Mental Health Debate
Canada Reconsiders Assisted Dying Eligibility Rules A Canadian parliamentary committee has recommended that individuals whose only medical condition is a mental illness should be excluded from eligibility for medical assistance in dying (MAID), marking a significant development in the country’s ongoing debate over assisted death laws. The recommendation was issued by a 17-member panel reviewing the legal
Canada Assisted Dying Rules Tightened Amid Mental Health Debate
Canada Reconsiders Assisted Dying Eligibility Rules A Canadian parliamentary committee has recommended that individuals whose only medical condition is a mental illness should be excluded from eligibility for medical assistance in dying (MAID), marking a significant development in the country’s ongoing debate over assisted death laws. The recommendation was issued by a 17-member panel reviewing the legal
Dr. Marty Makary Resigns as FDA Commissioner, Trump Announces
Dr. Marty Makary Resigns as FDA Commissioner Dr. Marty Makary has resigned from his position as the commissioner of the U.S. Food and Drug Administration (FDA), as confirmed by President Donald Trump on May 12. In a social media post, Trump revealed that Makary had informed him of his decision to step down, effective Tuesday. While Makary did not offer an explicit reason for his resignation, Trump praised his leadership, calling him a “hard worke
Dr. Marty Makary Resigns as FDA Commissioner, Trump Announces
Dr. Marty Makary Resigns as FDA Commissioner Dr. Marty Makary has resigned from his position as the commissioner of the U.S. Food and Drug Administration (FDA), as confirmed by President Donald Trump on May 12. In a social media post, Trump revealed that Makary had informed him of his decision to step down, effective Tuesday. While Makary did not offer an explicit reason for his resignation, Trump praised his leadership, calling him a “hard worke
Trump Drug Pricing Plan Could Cut $529B: Will Your Costs Drop?
The White House says aligning U.S. drug prices with global rates may slash costs—but experts remain divided. What the $529 Billion Savings Really Means According to White House economists, Trump’s drug pricing strategy—often called the “most favored nation” model—could reduce prescription drug costs by up to $529 billion over 10 years. The idea is simple: Americans s
Trump Drug Pricing Plan Could Cut $529B: Will Your Costs Drop?
The White House says aligning U.S. drug prices with global rates may slash costs—but experts remain divided. What the $529 Billion Savings Really Means According to White House economists, Trump’s drug pricing strategy—often called the “most favored nation” model—could reduce prescription drug costs by up to $529 billion over 10 years. The idea is simple: Americans s
New Insurance Laws In India: Will Claim Settlements Really Improve For Policyholders
India has ushered in a new phase of insurance regulation with Parliament clearing the Sabka Bima Sabki Raksha (Amendment of Insurance Laws) Bill, 2025, a move that comes at a time when trust between insurers and policyholders is increasingly strained. For millions of Indians, insurance is ultimately judged not by policy documents or premium receipts but by the ease and fairness of claim settlement. Delays, repeated document requests, late-stage exclusions, and opaque rejections have long plag
New Insurance Laws In India: Will Claim Settlements Really Improve For Policyholders
India has ushered in a new phase of insurance regulation with Parliament clearing the Sabka Bima Sabki Raksha (Amendment of Insurance Laws) Bill, 2025, a move that comes at a time when trust between insurers and policyholders is increasingly strained. For millions of Indians, insurance is ultimately judged not by policy documents or premium receipts but by the ease and fairness of claim settlement. Delays, repeated document requests, late-stage exclusions, and opaque rejections have long plag
FDA names Vinay Prasad as head of CBER, known for bold public health views
Vinay Prasad, a renowned oncologist-hematologist, has been appointed as the new director of the Center for Biologics Evaluation and Research (CBER) at the US Food and Drug Administration (FDA). This division of the FDA is charged with overseeing the evaluation and approval of critical biologic products, including vaccines, blood derivatives, and select gene-based therapies. Prasad’s appointment comes at a time when the FDA remains under public and political scrutiny for its handling of
FDA names Vinay Prasad as head of CBER, known for bold public health views
Vinay Prasad, a renowned oncologist-hematologist, has been appointed as the new director of the Center for Biologics Evaluation and Research (CBER) at the US Food and Drug Administration (FDA). This division of the FDA is charged with overseeing the evaluation and approval of critical biologic products, including vaccines, blood derivatives, and select gene-based therapies. Prasad’s appointment comes at a time when the FDA remains under public and political scrutiny for its handling of
Medicaid cuts could impact all DC residents, not just low-income patients
A new congressional proposal to reduce Medicaid funding for Washington D.C. is causing concern among officials and health experts, who warn that such cuts would have wide-reaching consequences beyond the program’s low-income beneficiaries. Medicaid is deeply integrated into the region’s health care infrastructure, and any funding reduction could disrupt care for patients across the income spectrum, affecting hospitals, clinics, and community health providers. House Rep
Medicaid cuts could impact all DC residents, not just low-income patients
A new congressional proposal to reduce Medicaid funding for Washington D.C. is causing concern among officials and health experts, who warn that such cuts would have wide-reaching consequences beyond the program’s low-income beneficiaries. Medicaid is deeply integrated into the region’s health care infrastructure, and any funding reduction could disrupt care for patients across the income spectrum, affecting hospitals, clinics, and community health providers. House Rep
Texas Hospitals Report Millions in Care for Undocumented Patients Amid Push for Annual Immigration Data
Preliminary data collected from hospitals across Texas reveals that tens of thousands of undocumented patients received medical treatment in recent months, costing the state’s health care system millions of dollars, according to testimony from a state health official this week. During a House Public Health Committee hearing on Monday, lawmakers reviewed a new bill introduced by Rep. Mike Olcott (R–Fort Worth) that would formalize Governor Greg Abbott’s 2024 executive order r
Texas Hospitals Report Millions in Care for Undocumented Patients Amid Push for Annual Immigration Data
Preliminary data collected from hospitals across Texas reveals that tens of thousands of undocumented patients received medical treatment in recent months, costing the state’s health care system millions of dollars, according to testimony from a state health official this week. During a House Public Health Committee hearing on Monday, lawmakers reviewed a new bill introduced by Rep. Mike Olcott (R–Fort Worth) that would formalize Governor Greg Abbott’s 2024 executive order r
Top Reasons Health Insurance Claims Get Rejected and How to Avoid Them
Health insurance is meant to be a safety net—helping individuals manage healthcare costs without financial stress. However, for many, that reassurance is shattered during claim time when their applications are denied. These rejections can leave policyholders not only frustrated but also suspicious about their insurer’s intentions. While some rejections are justified, many arise from avoidable mistakes that occur during policy purchase or while filing a claim. Understanding these e
Top Reasons Health Insurance Claims Get Rejected and How to Avoid Them
Health insurance is meant to be a safety net—helping individuals manage healthcare costs without financial stress. However, for many, that reassurance is shattered during claim time when their applications are denied. These rejections can leave policyholders not only frustrated but also suspicious about their insurer’s intentions. While some rejections are justified, many arise from avoidable mistakes that occur during policy purchase or while filing a claim. Understanding these e









